In this free webinar, learn about the benefits of multiplex respiratory panels tests for patient management, especially in the context of antimicrobial stewardship initiatives. Attendees will understand clinical situations in which a lowplex test is appropriate and when the additional diagnostic coverage provided by a multiplex test is justified. The featured speaker will discuss the risks of antimicrobial resistance and the implications of a robust antimicrobial stewardship program. The speaker will also discuss how real-time epidemiology tracking can support enhanced surveillance and faster responses to outbreaks.
TORONTO, Ontario, Dec. 8, 2022 /PRNewswire-PRWeb/ -- A return to pre-pandemic activities, coupled with a reduction in the population's collective immunity, has led to global surges in respiratory pathogens, including RSV and influenza. When several respiratory pathogens are circulating at once, rapid multiplex diagnostic testing can help healthcare providers (HCPs) more efficiently manage their patients. These tests increase opportunities for the detection of respiratory pathogens and can help avoid misdiagnosis due to overlapping clinical symptoms. And by eliminating diagnostic uncertainty, they can help HCPs decide when to start or stop antimicrobial therapy with more confidence.
With alarming increases in antimicrobial resistance rates, eliminating unnecessary antibiotic use has become more important than ever. Multiplex testing can be leveraged as the bridge between diagnostic stewardship and antimicrobial stewardship, advocating for the right test, in the right patient, at the right time.
Join featured speaker, Dr. Anooj Shah, for this interesting webinar as he walks through the benefits of multiplex diagnostic testing. He'll focus on the unique benefits offered by the QIAstat-Dx, a multiplex diagnostic real-time PCR-based system, including real-time epidemiology tracking.
Register now to learn more about leveraging rapid multiplex testing during the height of the respiratory season.
Join Anooj Shah, PharmD, MBA, BCIDP, Medical Science Liaison, Infectious Diseases, QIAGEN, for the live webinar on Monday, December 12, 2022, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Leveraging Rapid Multiplex Testing During the Height of Respiratory Season.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article